| Date | | |
|---|
| Jan 29th, 2017 | MedNous, Carlo Russo becomes CMO at Genenta Science |  |
| Jan 19th, 2017 | FierceBiotech, Ex-GSK rare disease head moves to Genenta | |
| Jan 19th, 2017 | Endpoints, GSK R&D vet Russo jumps to Genenta, takes a lead role in developing a new gene therapy | |
| Sep 26th, 2016 | BioCentury, Genenta Science, Amgen, Ospedale San Raffaele deal | |
| Sep 22nd, 2016 |
FierceBiotech, Genenta Science and Ospedale San Raffaele landed a deal with Amgen
|
|
| Sep 20th, 2016 | Labiotech, Italian Gene Therapy Biotech aims high by collaborating with US giant Amgen | |
| Sep 18th, 2016 | MedNous, Amgen to work with Italian scientists on new gene therapy | |
| Sep 16th, 2016 |
Endpoints, Protocols: Amgen partners with Genenta, San Raffaele on an anti-tumor drug
|
|
| Mar 24th 2016 | FierceBiotech, Manufacturing Agreement | |
| Mar 9th, 2015 |
BioCentury, Genenta Science financial update
|
|
| Mar 5th, 2015 | FierceBiotech, Italy’s Genenta Science raises $11M for gene therapy program at TIGET | |
| Jan 27th, 2015 | LaBiotech, Genenta Science raised €6.2M | |
| Jan 23rd, 2015 | FierceBiotech, Genenta Science raises €6.2M in first tranche of series A funding | |
| Jan 23rd, 2015 | BioCentury Extra, Gene therapy newco Genenta raises EUR 6.2M toward series A | |
| Jan 23rd, 2015 | BioWorld, Italian gene therapy start-up Genenta banks 7$M in series A round | |
